Silydianin (Silymarin Component C · Hepatoprotective · RNA Polymerase Modulator)

Compound	Silydianin (Silymarin Component C; Silidianin; minor silymarin flavonolignan)
Chemical class	Polyphenol — Flavonolignan (taxifolin-derived; structurally distinct from silybin/silychristin — spirocyclic lactone element)
CAS	29782-68-1
Primary source	Silybum marianum (milk thistle seeds — ~10% of the silymarin complex)
Key applications	Hepatoprotective; RNA polymerase modulation; antioxidant; anti-inflammatory
Claim strength	Moderate
Typical form	Organic Milk Thistle Extract Powder (silydianin co-delivered at ~10% of silymarin complex); Silymarin 70-80% extracts
Buy from Herbuno	Organic Milk Thistle (Silybum marianum) Extract Powder → Milk Thistle Seed Liquid Extract (Water Soluble) - Silybum marianum →

Name origin: Silydianin (also Silidianin) is named following the silymarin component naming convention: sily- (Silybum) + dianin (possibly from a researcher surname, following the historical pattern of flavonolignan naming in early silymarin chemistry). It is the third-largest component of the silymarin complex (~10% by weight), less studied than silybin and silychristin but contributing to the hepatoprotective activity of the whole silymarin preparation. Traditional use: Silydianin has no independent traditional use — it is a component of milk thistle seed extract's silymarin complex, with the same historical applications as described under the Silybin entry. Research trajectory: Silydianin is structurally unusual among silymarin flavonolignans — it contains a spirocyclic lactone ring system not present in silybin or silychristin, arising from a different taxifolin-cinnamic alcohol condensation geometry. This structural distinctiveness gives silydianin unique enzyme inhibition and receptor binding properties relative to the other silymarin components. Its most specifically characterised activity is RNA polymerase I and II inhibition — relevant to both hepatocyte regeneration support and antiproliferative (cancer research) applications. Commercial source: Silydianin is co-delivered in Organic Milk Thistle Extract Powder and Milk Thistle Seed Liquid Extract from Herbuno, as part of the standardised silymarin complex at approximately 10% of the flavonolignan fraction.

---

Evidence for Silydianin Applications

Hepatoprotective activity: Silydianin contributes to the hepatoprotective activity of the silymarin complex via antioxidant (Nrf2/HO-1 induction), anti-inflammatory (NF-κB suppression), and membrane-stabilising mechanisms. Its isolated potency in hepatotoxicity models is generally lower than silybin but comparable to silychristin. The synergistic hepatoprotective activity of the full silymarin mixture (silybin + silychristin + silydianin + isosilybin) exceeds that of any single component at equivalent total doses — supporting the use of whole silymarin preparations. Claim strength: Moderate.

RNA polymerase modulation: Silydianin inhibits RNA polymerase I transcription at higher concentrations than those stimulated by silychristin, and has been characterised as an inhibitor of RNA polymerase II — the enzyme responsible for mRNA synthesis — at micromolar concentrations in cell-based assays. The bidirectional Pol I effect (stimulation by silychristin, inhibition by silydianin at higher concentrations) within the silymarin complex may create a homeostatic balance in hepatocyte RNA synthesis during liver recovery. Pol II inhibition has antiproliferative implications relevant to cancer biology, though this represents an emerging research direction. Claim strength: Emerging.

Antioxidant: Silydianin's spirocyclic structure creates a unique spatial arrangement of phenolic hydroxyl groups — radical scavenging capacity is comparable to taxifolin and silychristin in DPPH and ABTS assays, though the spirocyclic lactone limits some metal chelation activity relative to the linear silybin structure. Claim strength: Moderate.

Anti-inflammatory: COX-2, NF-κB, and MAPK pathway inhibition have been characterised for silydianin in macrophage models, consistent with the silymarin class. TNF-α and IL-6 suppression complement silybin's and silychristin's anti-inflammatory profiles. Claim strength: Moderate.

---

Dosage & Formulator Specification

No isolated silydianin human dosing data exist. Silydianin is delivered as approximately 10% of standardised silymarin preparations. At the standard silymarin dose of 420 mg/day, silydianin contributes approximately 42 mg/day. At higher hepatitis/NAFLD doses (600–1400 mg silymarin/day), silydianin delivery is 60–140 mg/day.

For formulator specification: Organic Milk Thistle Extract Powder standardised to ≥70–80% silymarin delivers silydianin at 7–8% of total extract weight. Authentic silymarin HPLC fingerprint confirms the characteristic flavonolignan ratio (silybin ~50–60% : silychristin ~20% : silydianin ~10% : isosilybin ~5%); aberrant ratios indicate adulteration or misidentification with other Asteraceae plants.

The contribution of silydianin to the synergistic hepatoprotective activity of whole silymarin is mechanistically complementary to silybin and silychristin — supporting formulation of the full complex rather than isolated silybin for applications requiring comprehensive liver protection and regeneration support.

Safety profile is excellent within the established milk thistle safety record. No silydianin-specific safety concerns are identified. The spirocyclic lactone structure has not been associated with any toxicological concern at silymarin complex doses established in clinical use.

---

Frequently Asked Questions — Silydianin

What makes silydianin's structure unique among silymarin components?
Silybin and silychristin are formed by linear condensation of taxifolin with cinnamic alcohols via a benzodioxane linkage. Silydianin has a spirocyclic lactone ring — formed when the taxifolin-cinnamic alcohol condensation produces a cyclic lactone rather than the linear ether of silybin. This spirocyclic geometry creates a three-dimensionally distinct structure that interacts differently with enzyme active sites — explaining silydianin's unique RNA polymerase inhibition profile and different metal chelation characteristics.

Is silydianin studied independently or only as part of the silymarin mixture?
Predominantly as part of the silymarin mixture — silydianin is difficult to isolate in large quantities from milk thistle (representing only ~10% of silymarin), and its individual clinical study has not been commercially motivated. The biological research that has characterised silydianin's specific properties (RNA polymerase modulation, antioxidant mechanism) comes primarily from academic phytochemistry rather than pharmaceutical development programmes focused on individual silymarin components. Silybin attracts the most isolated compound research given its 50–60% abundance in silymarin and superior isolated efficacy in hepatotoxicity models.

Why is the full silymarin complex potentially superior to isolated silybin for some liver applications?
Three mechanisms suggest whole silymarin may outperform isolated silybin: (1) silychristin's RNA Pol I stimulation promotes hepatocyte regeneration — an activity absent from silybin; (2) silydianin's distinct enzyme interactions provide mechanistic complementarity to silybin's antioxidant/membrane-stabilising primary activity; (3) the combined antioxidant capacities of all four flavonolignans cover a broader reactive oxygen species spectrum than silybin alone. Multiple comparative studies show whole silymarin providing equivalent or superior hepatoprotective effects to silybin alone at equivalent total flavonolignan doses.

Does milk thistle quality vary significantly between suppliers and how can formulators verify it?
Yes — significantly. Common quality issues include: adulteration with other Asteraceae plant material; incorrect standardisation reporting (total extract weight vs. silymarin content); heat-induced silymarin degradation during extraction; and geographical variation in seed silymarin content (German/Italian-sourced seeds generally higher silymarin than non-European sources). HPLC fingerprint verification is the gold standard: authenticate the characteristic silybin:silychristin:silydianin:isosilybin ratio; verify silybin A and B diastereomer peaks; confirm absence of marker compounds from adulterant plants. Herbuno's milk thistle extracts should carry full CoA documentation with HPLC flavonolignan profiling.

Related compounds: Silybin, Silychristin, Taxifolin, Ampelopsin

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery